Thu, Dec 20, 2018 | By Soren H. Knudsen, Commercial Director, EMEA, Cryoport
The short answer is: YES!If a specimen or biological material can transition through the freezing point — as happens when frozen in refrigerators and/or packed in dry ice — then holding it at...
Mon, Nov 19, 2018 | By Kirk Randall, Senior Director, Business Development, Cryoport
Dry vapor shipping dewars used for transport of critical temperature-controlled biomaterials and lifesaving materials, such CAR-T and other regenerative medicines, can be purchased and used by...
Thu, Nov 08, 2018 | By Tom Heinzen, VP, Corporate Development & Investor Relations, Cryoport
The global commercial approval of the first CAR-T therapies (Kymriah® and Yescarta®) has intensified the need for the clear and uninterrupted flow of data from before the patient is ever treated...
Wed, Oct 31, 2018 | By Sue Blecman, Senior Director, Business Development, Cryoport
The tedious process of vendor selection for Clinical Trials, Commercialization Planning and Launch in Regenerative Medicine can be daunting, let alone having to think about the Support necessary...
Wed, Oct 03, 2018 | By Nathan Dai, Senior Director, Business Development, Cryoport
With today’s research collaboration, supply chain distribution, clinical and commercial programs spanning across continents, it is essential for pharmaceutical or biotechnology companies to safely...
Mon, Sep 24, 2018 | By Allie Gerber, Marketing Manager, Cryoport
In December 2016 the US Congress enacted the 21st Century Cures Act, which required the FDA to facilitate an efficient development program for, and expedite the review of, new medicines meeting...
Wed, Sep 12, 2018 | By Soren H. Knudsen, Commercial Director, EMEA, Cryoport
Moving time and temperature sensitive biological materials “smoothly” across the globe, from A to B, is and requires more than “just” acquiring compliant packaging material and booking a carrier…...
Tue, Sep 04, 2018 | By Ryan Carpentier, Sr. Director, Business Development, Cryoport
When considering your temperature-controlled logistics needs, it is important to think about the compliance consideration steps in the drug development and delivery process being more than just...
Mon, Aug 27, 2018 | By Colin Coffua, Vice President of Strategic Cryoport
Cryoport’s unique range of Cold Chain Logistics Solutions have been developed and implemented to support the most important and advanced drugs currently in the clinical development portfolios of...
Mon, Aug 20, 2018 | By Kirk Randall, Senior Director, Business Development, Cryoport
In our previous blog we discussed key considerations in the transport of critical biomaterials such as cell and gene therapies, in vitro fertilization shipments or large laboratory bio-sample...
Thu, Aug 02, 2018 | By Sue Blecman, Senior Director, Business Development, Cryoport
Successful research, development, manufacturing and commercialization in regenerative medicine is an epic challenge, with potentially a more epic reward of saving lives.Almost equally challenging...
Fri, Jul 27, 2018 | By Bruce Bowman, Sr. Director of Channel Sales, Cryoport
Graduating classes of young professionals all over the world are preparing to meet new challenges set before them as the embark on a journey. The lessons and academic content taught in their...
Tue, Jul 10, 2018 | By Mark W. Sawicki, Ph.D., Chief Commercial Officer, Cryoport
A carbon dioxide (CO2) shortage has been looming over the life sciences industry — yet many biopharma and biotech leaders alike have remained silent on this issue which is already shaking up our...
Thu, Oct 19, 2017 | By Allie Gerber, Marketing Manager, Cryoport
Cryoport is the leader in cryogenic and cold chain logistics solutions for the life sciences industry with their wide variety of Cryoport Express® dry vapor shippers, unparalleled informatics and...
Thu, Apr 13, 2017 | By Allie Gerber, Marketing Manager, Cryoport
Cryoport is the industry’s most trusted provider of cold chain logistics solutions for temperature-sensitive life sciences materials, serving biopharmaceutical, IVF and surrogacy and animal health...
Thu, Jan 19, 2017 | By Mark W. Sawicki, Ph.D., Chief Commercial Officer, Cryoport
Providing $6.3 billion in funding for medical innovation to expedite the discovery, development and delivery of new treatments and cures, the 21st Century Cures Act (Cures) received overwhelming...
Wed, Dec 14, 2016 | By Mark W. Sawicki, Ph.D., Chief Commercial Officer, Cryoport
Biopharmaceuticals are inherently fragile and temperature-sensitive, requiring exacting control of shipping and storage conditions to maintain product efficacy. This is especially critical for...
Wed, Nov 09, 2016 | By Mark W. Sawicki, Ph.D., Chief Commercial Officer, Cryoport
When planning your cold chain logistics strategy for temperature-sensitive biologic materials, a key consideration is minimizing risk to the quality of the commodity and its on-time delivery....
Wed, Sep 28, 2016 | By Mark W. Sawicki, Ph.D., Chief Commercial Officer, Cryoport
Today, an increasing number of therapeutics and vaccines for human and animal administration require shipment in specialized shipping containers often referred to as dewars or cryoshippers. Dewars...
Thu, Aug 11, 2016 | By Mark W. Sawicki, Ph.D., Chief Commercial Officer, Cryoport
Moving a laboratory can be stressful. No matter the scope of the relocation, the logistical and physical act of moving laboratories tends to be an inconvenience that disturbs the flow of...
Mon, Feb 29, 2016 | By Robert Hariri, M.D., Ph.D., Board of Directors, Cryoport
During the 2016 Super Bowl, New York-Presbyterian Hospital aired a 60-second advertisement, titled “Unmasking a Killer,” highlighting the hospital’s advanced cancer research and treatment. The ad...
Wed, Dec 02, 2015 | By Robert Hariri, M.D., Ph.D., Board of Directors, Cryoport
By Robert Hariri, M.D., Ph.D.
For years, there has been a need for logistics methodologies to keep pace with the developments in biology that require reliable and environmentally controlled...
Mon, Aug 10, 2015 | By Marketing Team, Cryoport
Another breeding season is coming to a close at Yancey Farms. Yancey Farms is one of the oldest and most respected warmblood breeders in the United States. They have been producing sporthorses of...
Tue, Jul 08, 2014 | By Marketing Team, Cryoport
The combination of dry ice, Styrofoam® and overnight shipping worked miracles in the 1960s and transformed medicine on the battlefield and here at home. Today, that combination remains a popular...
Wed, Jun 25, 2014 | By Marketing Team, Cryoport
U.S. • The Netherlands • Singapore
Sales • +1 949.232.1900 | Support • +1 949.470.2300
Thursday, May 31 | 11 a.m., ET
